Skip to main content
Lee's Pharmaceutical Holdings Limited logo

Lee's Pharmaceutical Holdings Limited — Investor Relations & Filings

Ticker · 950 ISIN · KYG5438W1116 LEI · 21380057SDS1LER3KZ63 HKEX Manufacturing
Open in API
Filings indexed 801 across all filing types
Latest filing 2026-05-21 Declaration of Voting R…
Country KY Cayman Islands
Listing HKEX 950

About Lee's Pharmaceutical Holdings Limited

http://www.leespharm.com

Lee's Pharmaceutical Holdings Limited is a research-driven and market-oriented biopharmaceutical company with over 30 years of operation. The company is fully integrated, possessing capabilities in drug development, clinical trials, manufacturing, marketing, and sales of internationally approved pharmaceutical products. Its core mission is centered on R&D of innovative products to address unmet medical needs and improve patients’ quality of life, primarily serving the pharmaceutical industry in China. The product portfolio, stemming from internal efforts and collaborations, addresses various therapeutic areas, including rare diseases (such as pulmonary hypertension) and dermatology. Manufacturing operations are supported by self-owned sites in Hefei and Nansha.

Recent filings

Filing Released Lang Actions
Annual General Meeting Held on 21 May 2026 - Poll Results
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is an announcement of poll results from the Annual General Meeting held on 21 May 2026, detailing vote counts for each resolution. It provides the official shareholder voting outcomes for the AGM, matching the definition of a Declaration of Voting Results announcement. Therefore, it should be classified as DVA.
2026-05-21 English
Connected Transaction - Investment in Partnership Fund
Regulatory Filings Classification · 78% confidence The document is a Hong Kong Stock Exchange announcement disclosing a connected transaction under Chapter 14A (an investment by the company’s subsidiary into a partnership fund). It is not a full financial report, interim/annual report, or earnings release; nor is it raising external funds or restructuring capital in the traditional sense of debt/equity issuance. It is a regulatory announcement required by listing rules, without substantive financial statements. Therefore it falls into the fallback “Regulatory Filings” category (RNS).
2026-05-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing for an equity issuer listed on the Hong Kong Stock Exchange, detailing movements in authorized share capital, issued shares, share options, and public float sufficiency confirmation. It includes confirmations pursuant to listing rules and is submitted by a company director. The content focuses on share capital movements and compliance confirmations rather than financial performance, earnings, or management commentary. It is a regulatory compliance filing related to share capital and public float status, not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2026-05-04 English
Notification Letter to Non-registered Shareholders and Reply Form
Report Publication Announcement Classification · 85% confidence The document is a ‘Notification Letter’ informing non-registered shareholders that the Company’s Annual Report and Circular have been published online, with instructions on how to obtain printed copies. It does not contain the actual financial content or Circular itself, but merely announces the publication and availability of those reports. Under the “Menu vs Meal” rule, this is a Report Publication Announcement.
2026-04-24 English
Notification Letter to Registered Shareholders and Reply Form
Report Publication Announcement Classification · 90% confidence The document is a shareholder notification dated 24 April 2026 informing registered shareholders that the Company’s annual report, circular and proxy form (collectively the “Current Corporate Communication”) have been published online and providing instructions for electronic dissemination and how to request printed copies. It does not contain the actual annual report or detailed financial data, but merely announces the publication and access arrangements. Therefore, it is a report publication announcement.
2026-04-24 English
Proxy Form
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a shareholder proxy form to solicit votes at the Annual General Meeting, including resolutions and instructions on appointing a proxy. This falls under Proxy Solicitation & Information Statement materials (PSI), rather than an AGM presentation, annual report, or simple announcement.
2026-04-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.